Lipoglycopeptide Antibacterial

This page covers all Lipoglycopeptide Antibacterial drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Marketed (4)

• Dalvance · AbbVie · Infectious Disease · 260.0
  Dalvance works by binding to the bacterial cell wall, disrupting its synthesis and ultimately leading to cell death.
• Orbactiv · Melinta Therap · Metabolic
  Orbactiv works by binding to the bacterial cell wall, disrupting its synthesis and ultimately leading to cell death.
• Vibativ · Cumberland · Metabolic
  Vibativ works by binding to the bacterial cell wall, disrupting its synthesis and ultimately leading to cell death.
• Vibativ · Cumberland · Metabolic